- ColonSentry® is an advanced blood-based molecular diagnostic test that measures the expression of seven gene biomarkers for the early detection of colorectal cancer.
- This 7‐gene, blood‐based biomarker panel can stratify subjects according to their current relative risk across a broad range in an average‐risk population.
- ColonSentry requires no fasting, dietary restrictions, or special instructions
- ColonSentry does not require patients to provide or handle any stool samples.
- ColonSentry is simple & convenient and blood can be drawn at an exam before patients leave the office.
ColonSentry® Patient Selection Criteria
The American Cancer Society recommends that people at average risk of colorectal cancer start regular screening at age 45. ³
Patients may be candidate for the ColonSentry® Test if they are:
- Age 45 or older and at average risk for Colorectal Cancer;
- Are without symptoms such as bleeding, abdominal pain, or change in bowel habits;
- Have not had a Colonoscopy or Stool-Based Screening Test.
³ American Cancer Society. Guideline for Colorectal Cancer Screening. Last revised May 30, 2018.